In a stride toward advancing neonatal and paediatric care, Owen Mumford, a leading medical
device manufacturer, has unveiled its latest innovation, the Unistik Heelstik. This pioneering
range of capillary blood sampling devices is tailored for newborns and older babies,
addressing the intricate challenges associated with this delicate demographic.
The unveiling of Owen Mumford’s Unistik Heelstik marks a pivotal moment in the sphere of neonatal and paediatric care, addressing the intricate challenges inherent in capillary blood sampling for these vulnerable patient populations.
Capillary blood sampling in neonatal and paediatric care demands an unparalleled level of
delicacy and precision due to the fragility of the patient population. The Unistik Heelstik
range, a testament to Owen Mumford’s dedication to pioneering medical solutions, introduces
four specialized devices meticulously tailored for the nuanced needs of distinct
developmental stages. The Micro Preemie device caters to the tiniest infants, navigating the
challenges unique to their extremely delicate condition. For Preemies, the device provides a
calibrated approach that balances precision with gentleness, ensuring optimal sampling
without discomfort.
Moving forward to the Full Term device, its design is optimized for infants transitioning into
a more stable developmental phase, maintaining a delicate balance between effectiveness and
comfort. Finally, the Toddler device, crafted for the older babies, exemplifies the evolution of
Owen Mumford’s commitment to providing safe, efficient, and minimally invasive sampling
techniques. Each device’s design intricately addresses the developmental milestones and
physical characteristics of these stages, guaranteeing a tailored and optimal experience for
both the infant and the healthcare professional conducting the procedure.
Owen Mumford’s Unistik Heelstik employs a lancet meticulously engineered to access only
superficial blood vessels, circumventing dermal pain fibres. This design not only ensures
precision but also minimizes the risk of discomfort for the baby. Guided by a visible
alignment arrow, the lancet allows for accurate positioning, ensuring a swift and optimal
procedure. The manual activation feature empowers users to confidently execute the device,
securing the right sample on the first attempt.
One of the most critical aspects of these devices is their compliance with the World Health
Organization’s guidelines for penetration depth. The Unistik Heelstik devices are calibrated
with varying penetration depths, ranging from 0.65mm for very small preterm babies to
1.5mm for toddlers. This calibrated approach, coupled with an automated retraction
mechanism upon contact, mitigates the risk of injury, reuse, and cross-infection, guaranteeing
a safer sampling experience for the infant and healthcare professional alike.
Adam Mumford, Director of Medical Devices at Owen Mumford, expressed,
The Unistik Heelstik range is a testament to our commitment to providing healthcare professionals with a diverse array of devices tailored to distinct developmental stages. Each device within this range encompasses unique parameters aimed at reducing discomfort and ensuring an effective and safe sampling procedure.
Furthermore, the Unistik Heelstik series boasts an extended shelf life, with individually
sealed devices ensuring sterility for a remarkable five years from the date of manufacture.
This commitment to durability and reliability underscores Owen Mumford’s dedication to
providing high-quality medical devices that adhere to the most stringent safety and efficacy
standards.
The Unistik Heelstik portfolio stands as a testament to Owen Mumford’s dedication to
enhancing neonatal and paediatric care. Its provision of specialized devices for four pivotal
ages and weights empowers healthcare professionals, ensuring safe and efficient blood
sampling. The Unistik Heelstik devices have the potential to revolutionize not only blood
sampling procedures but also the overall healthcare experience for infants and toddlers. By
significantly reducing discomfort and prioritizing safety, these devices instill confidence in
healthcare professionals while minimizing distress for both the infant and their families
during critical medical procedures.
This groundbreaking innovation promises a host of benefits:
● Reduced discomfort: Precision-designed lancets access superficial blood vessels,
minimizing pain.
● Enhanced safety: Compliance with WHO guidelines and an automated retraction
mechanism reduces the risk of injury and cross-infection.
● Extended shelf life: Individually sealed devices guarantee sterility for five years from
manufacture, ensuring reliability.
For more detailed information on the Unistik Heelstik range and its benefits, visit
https://www.owenmumford.com/en/medical-devices/unistik-heelstik
The Unistik Heelstik series by Owen Mumford embodies a significant leap forward in the
realm of neonatal and paediatric care. With its focus on safety, precision, and efficacy, these
devices herald a new era in blood sampling techniques, fostering confidence among
healthcare professionals and alleviating distress for the youngest patients. In summary, the
Unistik Heelstik series by Owen Mumford represents a pivotal advancement in neonatal and
paediatric care. Its precision-engineered lancets, adherence to global safety guidelines, and
commitment to minimising discomfort redefine the standards for blood sampling techniques,
reaffirming Owen Mumford’s leadership in advancing healthcare for the most vulnerable
patients.
No Comment! Be the first one.